C12N 2795/10041
Use of virus, viral particle or viral elements as a vector
C12N2795/10041 (Use of virus, viral particle or viral elements as a vector) appears on 46 US grants and 59 published applications in this corpus.
Search patents in C12N- Granted patents
- 46
- Published applications
- 59
- Assignees
- 53
- Inventors
- 127
- Latest grant
- 13 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 0 |
| 2003 | 1 | 2 |
| 2004 | 2 | 0 |
| 2005 | 1 | 0 |
| 2006 | 2 | 2 |
| 2007 | 1 | 2 |
| 2008 | 0 | 2 |
| 2009 | 1 | 0 |
| 2010 | 1 | 0 |
| 2011 | 1 | 2 |
| 2012 | 1 | 1 |
| 2013 | 1 | 2 |
| 2014 | 2 | 1 |
| 2015 | 1 | 3 |
| 2016 | 3 | 4 |
| 2017 | 1 | 2 |
| 2018 | 1 | 2 |
| 2019 | 4 | 5 |
| 2020 | 2 | 3 |
| 2021 | 2 | 3 |
| 2022 | 2 | 7 |
| 2023 | 5 | 8 |
| 2024 | 0 | 2 |
| 2025 | 1 | 4 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2795/10043Viral genome or elements thereof as genetic vectorIndexing code38
- C12N 2795/10042Virus or viral particle as vehicleIndexing code8
- C12N 2795/10045Special targeting system for viral vectorsIndexing code7
- C12N 2795/10044Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code0
Recent patents
- Production and functionalization of nanoparticles derived from phage T5 and therapeutic uses13 Jan 2026US 12,521,432 B2Centre National de la Recherche Scientifique (CNRS)
- Devices and methods for detecting microorganisms using recombinant reproduction-deficient indicator bacteriophage9 Dec 2025US 12,492,421 B2Laboratory Corporation of America Holdings
- Compositions and methods for nucleic acid expression and protein secretion in Bacteroides26 Sep 2023US 11,766,461 B2The Board of Trustees of the Stanford Junior
- Devices and methods for detecting microorganisms using recombinant reproduction-deficient indicator bacteriophage29 Aug 2023US 11,739,363 B2Laboratory Corporation of America Holdings
- Methods for producing mutant bacteriophages for the detection of listeria13 Jun 2023US 11,674,124 B2Laboratory Corporation of America Holdings
- Systems for production of transducing particles, methods, kits, compositions and uses thereof26 Mar 2026US 2026/0083787 A1Ramot at Tel-Aviv University Ltd.
- Devices and Methods for Detecting Microorganisms Using Recombinant Reproduction-Deficient Indicator Bacteriophage12 Mar 2026US 2026/0071250 A1
- Phage compositions for escherichia comprising crispr-cas systems and methods of use thereof13 Nov 2025US 2025/0345378 A1Locus Biosciences, Inc.
- Compositions and methods for treating wilson's disease16 Oct 2025US 2025/0320509 A1The Johns Hopkins University
- Targeting e coli cells26 Jun 2025US 2025/0205293 A1SNIPR Biome ApS
Most cited
By later US patents
- Receptor-mediated gene delivery using bacteriophage vectors63US 6,054,312 ASelective Genetics, Inc. · 2000
- Internalizing ERB2 antibodies42US 7,244,826 B1The Regents of the University of California · 2007
- 25 KD coccidial antigen of eimeria tenella24US 5,279,960 AEnzon, Inc. · 1994
- Internalizing ErbB2 antibodies20US 7,892,554 B2The Regents of the University of California · 2011
- Receptor-mediated gene delivery using bacteriophage vectors17US 6,448,083 B1Selective Genetics, Inc. · 2002